Vytlačiť
1.
- Pegylated interferon alfa-2a in patients with essential thrombocythaemia or polycythaemia vera: a post-hoc, median 83 month follow-up of an open-label, phase 2 trial / Masarova L. ... [et al.]. The Lancet Haematology. - Vol. 4, no. 4 (2017), s. 165-175 [Dokument nie je vo fonde knižnice]